Subjects - Business

There are a number of critical issues to master in the art of creativity and innovation management:

• What are t

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

he critical differences between creativity and innovation? Are different competencies required?

• Do "creative p

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

eople" have common characteristics and, if so, what are they? Are they stable across situations?

• Can creativit

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

y be learned and developed or is it a special gift? Why is it that some people just are more creative?

• Why is

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

otivation more important than nature or nurture? How can it be enhanced, measured and managed?

• Blocks and unlo

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

cking. Organisational culture. We can all be more creative, so what is stopping us? What properties of an organis

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ational culture cultivate productivity?

• What properties of an organisational structure foster creativity and i

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

novation? Organisational structure results from a number of factors and modifying it is often not desireable, so

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

how do we get around this?

• What is the most effective team structure?

• What is the role of knowledge? How do

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

we effectively collaborate and use networks to frame-break and reduce path dependency? How do we tap into tacit

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

nowledge? Does mastering all the literature foster creativity and innovation or does over-specialisation cause bl

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

inkered vision?

• What are the differences between radical and incremental creativity and the consequences for s

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

tructures, processes, skills and resources? Is it wiser to target radical or incremental ideas?

• Is there value

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

in structure and goals or is "do your best" more effective?

• Is there a process that makes insight, eureka, th

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

aha! experience more likely? Does this process allow us to produce a stream of consistently good ideas?

• How d

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

o we value an idea, so as to decide how to invest resources? How do we risk manage the innovation process

Learn

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

more…

The Complete MBA dissertation on Managing Creativity and Innovation can be found at y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

href="http://managing-creativity.com/">http://managing-creativity.com

You can also receive a regular, free n

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ewsletter by entering your email address at this site.

Kal Bishop, MBA

**********************************

You

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

are free to reproduce this article as long as no changes are made and the author's name and site URL are retained

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/23628/subjects-MBA-Dissertation-Managing-Creativity-and-Innovation.html">MBA Dissertation: Managing Creativity and Innovation</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/23628/subjects-MBA-Dissertation-Managing-Creativity-and-Innovation.html]MBA Dissertation: Managing Creativity and Innovation[/url]

Millions of business phone calls are made every hour and day. Business people that interact solely over the phone yet never meet still form strong opinions of one another. Practising good business phone etiquette helps encourage clear lines of communication, build rapport and avoid misunderstandings.

There were over two dozen break-out sessions during the 2 1/2 days and we did our best to cover them. The panels in each session were made up of marque companies like CNN, AOL, and Frito Lay as well as one person entrepreneurs and everything in between. As always there were actionable strategies from every quarter.

Nervous about your first photo shoot. Read this article to find out what you should bring.

Tags

Links

Subjects - MBA Dissertation: Managing Creativity and Innovation

Related Articles: